Ronald Kocak
Fortuna: 12 066 $ al 31/07/2026
Fortuna: 12 066 $ al 31/07/2026
Mr. Ronald B. Kocak, CPA, is a Vice President-Finance & Controller at RenovoRx, Inc., a Member at Chartered Global Management Accountant, a Member at The American Institute of Certified Public Accountants and a Member at The Association of Bioscience Financial Officers.
Mr. Kocak was previously employed as a Chief Accounting Officer & Controller by Nabi Biopharmaceuticals and a Senior Director-Finance & Controller by Sensei Biotherapeutics, Inc. He received his undergraduate degree from Duquesne University of The Holy Spirit.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RENOVORX, INC. 0,03 % | 01/07/2025 | 12.595 ( 0,03 % ) | 12 066 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RENOVORX, INC. | Comptroller/Controller/Auditor | 01/10/2021 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Corporate Officer/Principal | - |
Chartered Global Management Accountant | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Comptroller/Controller/Auditor | 01/01/2013 |
| FAETH THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
RenovoRx, Inc.
RenovoRx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapies for the local treatment of solid tumors | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Duquesne University of The Holy Spirit
Duquesne University of The Holy Spirit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
Chartered Global Management Accountant | |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.